Trial Outcomes & Findings for Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI) (NCT NCT03245723)

NCT ID: NCT03245723

Last Updated: 2021-02-04

Results Overview

Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

52 participants

Primary outcome timeframe

Visit 1 (1 day)

Results posted on

2021-02-04

Participant Flow

Out of 52 enrolled participants, no data was collected for 2 participants due to COVID. 50 participants were allocated to intervention.

Participant milestones

Participant milestones
Measure
Preterm
Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Term - Healthy Controls
Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Overall Study
STARTED
32
18
Overall Study
COMPLETED
27
17
Overall Study
NOT COMPLETED
5
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Preterm
Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Term - Healthy Controls
Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Overall Study
Bigeminy precluding hypoxia exposure
1
0
Overall Study
Claustrophobia from wearing the mask
1
0
Overall Study
Having to abruptly stop the scan to use the restroom
2
0
Overall Study
Image acquisition/reconstruction failure
1
1

Baseline Characteristics

Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Preterm
n=32 Participants
Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Term - Healthy Controls
n=18 Participants
Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Total
n=50 Participants
Total of all reporting groups
Age, Continuous
26.1 years
STANDARD_DEVIATION 4.2 • n=5 Participants
25.4 years
STANDARD_DEVIATION 4.0 • n=7 Participants
25.75 years
STANDARD_DEVIATION 4.1 • n=5 Participants
Sex: Female, Male
Female
23 Participants
n=5 Participants
10 Participants
n=7 Participants
33 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
8 Participants
n=7 Participants
17 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
31 Participants
n=5 Participants
16 Participants
n=7 Participants
47 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
30 Participants
n=5 Participants
16 Participants
n=7 Participants
46 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Gestational age (Neonatal Characteristics)
29.2 Weeks
STANDARD_DEVIATION 2.5 • n=5 Participants
39.8 Weeks
STANDARD_DEVIATION 1.0 • n=7 Participants
34.5 Weeks
STANDARD_DEVIATION 1.75 • n=5 Participants
Birth weight (Neonatal Characteristics)
1225 Grams
STANDARD_DEVIATION 397 • n=5 Participants
3397 Grams
STANDARD_DEVIATION 572 • n=7 Participants
2311 Grams
STANDARD_DEVIATION 484.5 • n=5 Participants

PRIMARY outcome

Timeframe: Visit 1 (1 day)

Population: Data was not collected for 4 preterm participants due to following reasons: * bigeminy precluding hypoxia exposure (N=1), * claustrophobia from wearing the mask (N=1), * having to abruptly stop the scan to use the restroom (N=2).

Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

Outcome measures

Outcome measures
Measure
Preterm
n=28 Participants
Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Term - Healthy Controls
n=18 Participants
Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Cardiac Glucose Uptake During Normoxic Rest (µg/Min)
0.689 µg/min
Standard Deviation 0.546
0.540 µg/min
Standard Deviation 0.454

PRIMARY outcome

Timeframe: Visit 1 (1 day)

Population: 5 preterm and 1 term participants did nor receive the allocated intervention due to : * bigeminy precluding hypoxia exposure (N=1 preterm), * claustrophobia from wearing the mask (N=1 preterm), * having to abruptly stop the scan to use the restroom (N=2 preterm). * image acquisition/reconstruction failure (n = 2,1 preterm and 1 term)

Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

Outcome measures

Outcome measures
Measure
Preterm
n=27 Participants
Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Term - Healthy Controls
n=17 Participants
Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Pulmonary Function Testing: Subjects will undergo Spirometry and Plethysmography Electrocardiogram: Subjects will undergo an electrocardiogram to ensure sinus rhythm Positron Emission Tomography: Subjects will undergo positron emission tomography to detect images of the heart Magnetic Resonance Imaging: Subjects will undergo positron magnetic resonance imaging to detect images of the heart
Change in Glucose Uptake From Normoxia to Hypoxia (µg/Min)
-0.264 µg/min
Standard Deviation 0.588
-0.003 µg/min
Standard Deviation 0.390

Adverse Events

Preterm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Term - Healthy Controls

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Kara Goss

UT Southwestern Medical Center, Dallas, Texas

Phone: 214-648-6868

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place